CVS Health Updates EPS Guidance and Operational Plans

CVS Health Updates Full-Year EPS Guidance, Implements Operational Enhancements

CVS Health Corporation (NYSE: CVS) has announced its Q2 2024 financial results, revealing adjusted earnings per share (EPS) of $1.83 and an adjusted operating income of $3.7 billion. The company reported total revenues exceeding $91 billion, with an operating cash flow of $8 billion for the first half of the year. Despite challenges in certain segments, CVS Health has updated its full-year adjusted EPS guidance to between $6.40 and $6.55 and is initiating strategic moves to improve operational performance and value delivery.